|
Douglas Lundin PhD
Chief economist
TLV
SKÖNDAL
Sweden
|
Douglas Lundin is chief economist at the TLV, which is the Swedish reimbursement agency for pharmaceuticals. He has had this position since 2011. He has a PhD from Uppsala University and did his post doc at the Center for Health Economics, Stockholm School of Economics. During the last years he has worked on government commissioned projects regarding HTA and payment models for precision medicine and ATMPs.